POSTER SESSION III
Tuesday, March 23, 2010 — 9:30 AM - 12:00 Noon
Exhibit Hall
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
BONE & SOFT TISSUE PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
1
Diagnostic Utility of a Novel ETV6/NTRK3 RT-PCR Assay and Break-Apart ETV6 FISH Analysis in the Diagnosis of Congenital Fibrosarcoma and Cellular/Mixed Congenital Mesoblastic Nephroma
(83)
A Igbokwe, AJ Lazar, WL Wang, A Folpe, V Hernandez, J Hicks, D Lopez-Terrada - Baylor College of Medicine, Houston, TX; UT-MD Anderson Cancer Center, Houston, TX; Mayo Clinic, Rochester, MN
Recurrent (2;2) and (2;8) Translocations in Rhabdomyosarcoma without the Canonical PAX-FOXO1 Fuse PAX3 to Members of the Nuclear Receptor Transcriptional Coactivator Family
(55)
JA Bridge, R Streblow, RW Frayer, P Dal Cin, A Rosenberg, A Meloni-Ehrig, J Sumegi - University of Nebraska Medical Center, Omaha, NE; Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Harvard Medical School, Boston, MA; Massachusetts General Hospital, Boston, MA; Quest Diagnostics Nichols Institute, Chantilly, VA
p63 Immunohistochemistry Is a Useful Marker for Muscle Differentiation
(94)
SE Martin, MP Gohen, TM Ulbright, EM Hattab - Indiana University School of Medicine, Indianapolis, IN
Adamantinoma and Osteofibrous Dysplasia: Diagnostic Application of p63 with Additional Evidence for a Pathophysiologic Relationship
(71)
BC Dickson, RS Bell, PC Ferguson, DJC Howarth, KPH Pritzker, JS Wunder, RA Kandel - Mount Sinai Hospital; University of Toronto, Toronto, ON, Canada; Toronto General Hospital, Toronto, ON, Canada; Mount Sinai Hospital, Toronto, ON, Canada
Immunohistochemical Staining for TLE1 Distinguishes Synovial Sarcoma from Histologic Mimics
(77)
WC Foo, MR Wick, JL Hornick - Brigham and Women's Hospital, Harvard Medical School, Boston, MA; University of Virginia Medical Center, Charlottesville, VA
CD1a Immunopositivity in Perivascular Epithelioid Cell Neoplasms (PEComas): True CD1a Expression or Technical Artifact?
(48)
WA Ahrens, AL Folpe - Carolinas Medical Center, Charlotte, NC; Mayo Clinic, Rochester, MN
A Subset of PEComas Harbor TFE3 Gene Fusions
(50)
P Argani, P Illei, G Netto, J Ro, HY Cho, S Dogan, M Ladanyi, G Martignoni, S Aulmann, SW Weiss - Johns Hopkins Medical Institutions, Baltimore, MD; Asan Medical Center, Seoul, Korea; Memorial Sloan-Kettering Cancer Center, New York, NY; University of Verona, Verona, Italy; University of Heidelberg, Heidelberg, Germany; Emory University, Atlanta, GA
Morphologic Patterns of Residual Viable Osteosarcoma in Neoadjuvant-Chemotherapy Treated Patients: A Clinico-Pathologic Study of 101 Cases at a Single Institution
(59)
MJ Cascio, RJ O'Donnell, AE Horvai - UCSF, San Francisco
Osteosarcoma of the Jaw Bones: A Clinicopathologic Study of 44 Cases
(102)
Y Nakashima, E Konishi, Y Iwasa - Kyoto University Hospital, Kyoto, Japan; Kyoto Prefectural Medical School, Kyoto, Japan; Osaka City University School of Medicine, Osaka, Japan
Chondroblastoma-Like Osteosarcoma: A Clinicopathologic Review of 17 Cases
(52)
A Bahrami, K Unni, F Bertoni, P Bacchini, H Dorfman, T Nojima, C Inwards - Mayo Clinic, Rochester; Casa di Cura Villa Erbosa, Bologna, Italy; Montefiore Medical Center, New York; Kanazawa Medical University, Uchinada, Japan
MDM2 and CDK4 Immunoreactivity Distinguishes Low-Grade Osteosarcoma from Benign Mimics
(124)
A Yoshida, T Ushiku, T Motoi, M Fukayama, H Tsuda - National Cancer Center Hospital, Tokyo, Japan; University of Tokyo, Tokyo, Japan; Teikyo University, Tokyo, Japan
Establishment of a New Human Osteosarcoma Cell Line, UTOS-1: Cytogenetic Characterization by Array Comparative Genomic Hybridization
(123)
T Yasuda, M Kanamori, T Hori, K Suzuki, S Nogami, T Kimura - University of Toyama, Toyama, Japan; Takaoka City Hospital, Takaoka, Toyama, Japan
Functional and Phenotypical Analysis of 19 EuroBoNet Osteosarcoma Cell Lines
(98)
AB Mohseny, I Machado, Y Cai, KL Schaefer, PC Hogendoorn, A Llombart-Bosch, AM Cleton-Jansen - Leiden University Medical Center, Leiden, Netherlands; University of Valencia, Valencia, Spain; Shandong University, Jinan, China; University Medical Center Duesseldorf, Duesseldorf, Germany
Expression of Heat Shock Proteins in Osteosarcomas
(100)
A Moon, P Bacchini, F Bertoni, YW Kim, YK Park - Kyung Hee Univercity, Seoul, Republic of Korea; Villa Erbosa Hospital, Bologna, Italy; Rizzoli Institute, Univercity of Bologna, Bologna, Italy
Prognostic Analysis of Protein Expression by Tissue Microarray in Osteosarcoma
(118)
K Suzuki, J Fukuoka, M Kanamori, T Yasuda, T Hori, T Kimura - University of Toyama, Toyama, Japan; Toyama University Hospital, Toyama, Japan
Morphologic and Immunohistochemical Characterization of a Series of Clinically Atypical Skull Base Chordomas in the Paediatric Population
(89)
CH Lee, NJ Liebsch, GP Nielsen, A Ganguly, AE Rosenberg - Vancouver General Hospital, Vancouver, BC, Canada; Massachusetts General Hospital, Boston, MA
Mammalian Target of Rapamycin Is Constitutively Activated in Chordomas
(73)
CT Elkins, PD Zhang, T Scharschmidt, J Mayerson, OH Iwenofu - Ohio State University, Columbus, OH; Hospital of the University of Pennsylvania, Philadelphia, PA
INI-1 Expression in Cytokeratin-Positive Tumors of Bone
(119)
R Tirabosco, AM Flanagan - Royal National Orthopaedic Hospital, London, United Kingdom; University College London, London, United Kingdom
Chondroid Tenosynovial Giant Cell Tumor of the Temporomandibular Joint: Clinicopathologic and Immunohistochemical Analysis of 5 New Cases
(114)
GJ Smalberger, R Garcia, BL Hoch - University of Washington, Seattle, WA; Mount Sinai Medical Center, New York, NY
The Analysis of Cytogenetics of Giant Cell Tumors
(85)
M Kanamori, T Yasuda, K Suzuki, T Hori, T Kimura - University of Toyama, Toyama City, Toyama, Japan
Aneurysmal Bone Cyst with Dual Rearrangements of SS18 and USP6
(78)
KB Geiersbach, LS Rector, A Hooker, LJ Layfield, ST South - University of Utah School of Medicine, Salt Lake City, UT; ARUP Laboratories, Salt Lake City, UT
Characterization of Rare Chondrosarcoma Subtypes
(95)
D Meijer, K Szuhai, BE van den Akker, D de Jong, T Krenacs, NA Athanasou, AM Flanagan, P Picci, S Daugaard, B Liegl-Atzwanger, PC Hogendoorn, JV Bovee - On Behalf of the EuroBoNet Consortium, http://www.eurobonet.eu/ , Leiden, Netherlands
A Pro-Inflammatory Tumor Microenvironment with High Chemokine Expression and High Tumor-Infiltrating CD3+CD8+ Numbers Associates with Improved Survival in Ewing Sarcoma
(53)
D Berghuis, SJ Santos, JJ Baelde, AHM Taminiau, RM Egeler, MW Schilham, PCW Hogendoorn, AC Lankester - Leiden University Medical Center, Leiden, Netherlands
Ezrin Immunoexpression in Bone Sarcomas (Osteo-Chondrosarcomas and Ewing/PNET)
(92)
A Llombart-Bosch, I Machado, S Navarro, M Alberghini, F Bertoni - Valencia University, Valencia, Spain; The Rizzoli Orthopedic Institute, Bologna, Italy
Phosphorylated Ezrin Is Located in the Nucleus of the Osteosarcoma Cell In Vitro and In Vivo
(70)
C Di Cristofano, M Leopizzi, A Miraglia, B Sardella, V Moretti, A Ferrara, V Petrozza, C Della Rocca - Sapienza University of Rome, Polo Pontino, ICOT, Latina, Italy
Primary Cilia Organization Orchestrating Cell Polarity in the Growth Plate and Its Loss in Osteochondroma
(65)
CE de Andrea, M Wiweger, JVMG Bovee, S Romeo, PCW Hogendoorn - Leiden University Medical Center, Leiden, Netherlands; Treviso Regional Hospital, Treviso, Italy
Diagnostic Accuracy of Core Needle Biopsy of Bone Lesions: Analysis of 230 Cases
(79)
G Gonlusen, E Calis, M Ergin, S Erdogan, C Ozkan - Cukurova University Medical Faculty, Adana, Turkey
Ultrastructural Organisation of Cartilage in Proteoglycan-Deficient Zebrafish Mutants
(122)
M Wiweger, C Avramut, F Prins, RBG Ravelli, PCW Hogendoorn - LUMC, Leiden, Netherlands
button next to any title to add to Itinerary Planner...
Add
